WebCyproterone acetate has been associated with an overall rare, but cumulative dose-dependent, increased risk of meningioma (single and multiple), mainly at doses of 25 … WebFeb 19, 2024 · Background The relationship between increased meningioma incidence and growth and long-term hormonal therapy with cyproterone acetate (CPA) in women has been recently established in literature. Following the raise in awareness from hormonal treatment, we describe a potential relationship between the progesterone agonist …
Risk of meningioma among users of high doses of cyproterone …
WebCyproterone-containing medicinal products. (first published 27/03/2024; last update 20/05/2024) 6 ... Nguyen P et al. Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study. BMJ 2024;372:n37 (doi: 10.1136/bmj.n37) 8 Traitement hormonal substitutif de la ménopause et méningiomes. La Revue Prescrire … WebCebula H, Pham TQ, Boyer P, Froelich S. Regression of meningiomas after discontinuation of cyproterone acetate in a transsexual patient. Acta Neurochir (Wien) 2010; 152:1955. … crtanje deda mraza korak po korak
Is cyproterone acetate causing intracranial meningiomas?
WebJan 2, 2024 · A conservative approach with interruption of cyproterone acetate may be a sufficient intervention, obviating the need for additional neurosurgical treatment of a trans woman diagnosed with a meningioma. ABSTRACT Background: Meningiomas express estrogen and progesterone receptors, suggestive of hormonal responsiveness. So far, … WebJul 12, 2024 · If a patient treated with cyproterone acetate is diagnosed with meningioma, treatment with all cyproterone-containing products must be permanently stopped. … WebCyproterone acetate has been associated with an overall rare, but cumulative dose-dependent, increased risk of meningioma (single and multiple), mainly at doses of 25 … crtanje cveta